Scarica l'app Stockscreener
2.045
3.97%
-0.095
Milestone Pharmaceuticals Inc Azioni (MIST) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Research and Development |
33.25%
3.639
|
5.452 | 6.721 | 8.622 | 10.26 |
| Interest Income/Expense |
1.75%
0.872
|
0.857 | 0.841 | 0.82 | 0.036 |
| Operating Income/Loss |
24.09%
-10.48
|
-13.80 | -15.36 | -16.44 | -15.50 |
| Income/Loss From Continuing Operations Before Tax |
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
| Income/Loss From Continuing Operations After Tax |
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
Net Income/Loss
|
23.93%
-10.35
|
-13.61 | -15.08 | -16.04 | -14.95 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
34.37%
-0.21
|
-0.32 | -0.35 | -0.37 | -0.35 |
| Diluted Earnings Per Share |
34.37%
-0.21
|
-0.32 | -0.35 | -0.37 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.39%
8.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):